Global Non-Invasive Respiratory Therapy Market Size is valued at USD 2.45 Bn in 2024 and is predicted to reach USD 4.04 Bn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034.
Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma, sleep apnea, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (ARDS). Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. Continuous technological breakthroughs have resulted in the creation of more efficient, user-friendly, and portable non-invasive respiratory equipment.
Smart inhalers, wearable gadgets, and telemedicine solutions improve the patient experience and adherence to therapy. Factors such as rising respiratory illnesses and a surge in demand for non-invasive procedures are expected to drive market expansion in the coming years. Furthermore, benefits connected with various non-invasive (NIV) ventilators are other variables related to increased device acceptance and market expansion.
However, the emergence of the COVID-19 pandemic had a substantial impact on the market under consideration. Because of the pandemic's abrupt onset, the market saw a short-term negative impact due to decreased patient visits to hospitals and clinics. However, in the later stages of the pandemic, the market experienced tremendous growth due to increasing demand for NIV for COVID-19 patients and other chronic respiratory illness patients.
The Non-Invasive Respiratory Therapy Market is segmented on the basis of product, application, and end-use. As per the product, the market is divided into Non-invasive Positive-pressure Ventilator (PPV) and non-invasive Negative Pressure Ventilator (NPV). The Positive-pressure Ventilator (PPV) segment includes Bi-level Positive Airway Pressure Ventilator (BiPAP), Constant Positive Airway Pressure Ventilator (CPAP), and Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP). According to the application, the market consists of Asthma & Chronic Obstructive Pulmonary Disease (COPD), respiratory distress syndrome, and Others. The end-user segment includes Hospitals, Ambulatory Surgical Centers (ASCs), and Others.
The Constant Positive Airway Pressure Ventilator (CPAP) category is expected to hold a major share in the global Non-Invasive Respiratory Therapy Market in 2024. This is due to the fact that Continuous Positive Airway Pressure (CPAP) is a type of positive airway pressure used to maintain a constant pressure during both inspiration and expiration. The use of CPAP preserves PEEP, reduces atelectasis, increases alveolar surface area, improves Ventilation/Perfusion (V/Q) matching, and hence improves oxygenation. While CPAP alone is frequently insufficient for sustaining ventilation, extra pressure support during inspiration in the form of Inspiratory Positive Airway Pressure (IPAP) or Bilevel Positive Airway Pressure (BiPAP) for non-invasive ventilation is required.
The Asthma & Chronic Obstructive Pulmonary Disease (COPD) segment is projected to rapid growth in the global Non-Invasive Respiratory Therapy Market. Asthma and COPD problems are becoming more common, which has contributed to the rise in their prevalence. According to the WHO, COPD is the world's third leading reason of death, accounting for 3.23 million fatalities. Low- and middle-income countries (LMIC) account for around 90% of COPD fatalities among people under the age of 70. Tobacco use is responsible for more than 70% of COPD cases in high-income nations and 30%-40% of COPD cases in low- and middle-income countries, with household air pollution being a major risk factor. Furthermore, new product launches by prominent companies are projected to boost revenue growth in this market.
The North American non-invasive Respiratory Therapy Market is expected to record the maximum market revenue share in the near future, attributed to the increased frequency of respiratory illnesses. The market in the United States will account for the highest share in 2024, owing to technical improvements in non-invasive ventilators and the rising frequency of respiratory illnesses. According to the American Lung Association, approximately 34 million Americans are affected by chronic respiratory disorders, which include asthma and COPD, as well as emphysema and chronic bronchitis. Furthermore, new technical breakthroughs in mechanical ventilators will likely fuel this region's market revenue growth throughout the projection period. Moreover, Europe is expected to grow significantly within the forecast period. This is because of the rising incidence of respiratory illnesses and technological developments in non-invasive ventilators, as well as the country's rising prevalence of sleep apnea.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 2.45 Bn |
|
Revenue Forecast In 2034 |
USD 4.04 Bn |
|
Growth Rate CAGR |
CAGR of 5.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, Product, End-Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
ResMed Inc., Teleflex Incorporated, Hamilton Medical, Koninklijke Philips N.V., Heyer Medical AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Airon Corporation, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Baxter International Inc., WILAmed GmbH, Getinge AB, and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Non-Invasive Respiratory Therapy Market Snapshot
Chapter 4. Global Non-Invasive Respiratory Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product:
5.2.1. Non-invasive Positive-pressure Ventilator (PPV)
5.2.1.1. Bi-level Positive Airway Pressure Ventilator (BiPAP)
5.2.1.2. Constant Positive Airway Pressure Ventilator (CPAP)
5.2.1.3. Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP)
5.2.2. Non-invasive Negative-pressure Ventilator (PPV)
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Respiratory Distress Syndrome
6.2.2. Asthma & Chronic Obstructive Pulmonary Disease (COPD)
6.2.3. Others
Chapter 7. Market Segmentation 3: By End-use Estimates & Trend Analysis
7.1. By End-use & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-use:
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers (ASCs)
7.2.3. Others
Chapter 8. Non-Invasive Respiratory Therapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
8.1.2. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts By End-use, 2021-2034
8.1.4. North America Non-Invasive Respiratory Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2021-2034
8.2.2. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2021-2034
8.2.4. Europe Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, 2021-2034
8.3.2. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, 2021-2034
8.3.4. Asia Pacific Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
8.4.2. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.4.4. Latin America Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Non-Invasive Respiratory Therapy Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ResMed Inc.
9.2.2. Teleflex Incorporated
9.2.3. Hamilton Medical
9.2.4. Koninklijke Philips N.V.
9.2.5. Heyer Medical AG
9.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
9.2.7. Airon Corporation, Drägerwerk AG & Co. KGaA
9.2.8. Fisher & Paykel Healthcare Limited
9.2.9. Baxter International
9.2.10. WILAmed GmbH
9.2.11. Getinge AB
Non-Invasive Respiratory Therapy Market By Product-
Non-Invasive Respiratory Therapy Market By Application-
Non-Invasive Respiratory Therapy Market By End-Use-
Non-Invasive Respiratory Therapy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
